Vanda Pharmaceuticals Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.00

-0.12 (-2.25%)

As of Aug 9, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +209.0% upside

Low Target $11.33

Average Target $15.45

High Target $18.37

Current Price $5.00

Current
$5.00

Target
$15.45

$11.33 $15.45 avg $18.37

Scenario Analysis

Bear Case

$11.33

126.6%

Low target

Base Case

$15.45

+209.0%

Avg target

Bull Case

$18.37

+267.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$9.94

-49.7% from high

52-Week Low

$4.14

+20.8% from low

Target vs 52W High

$15.45

+55.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%